Navigation Links
Oramed Pharmaceuticals Announces Withdrawal of Proposed Underwritten Public Offering
Date:6/21/2013

s, or when we discuss our clinical trials. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; laboratory results that do not translate to equally good results in real settings; our patents may not be sufficient; and final that products may harm recipients, all of which could cause the actual results or performance of Oramed to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Oramed undertakes no obligation to publicly release any revisions to these forward-looking statements to
'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
2. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
3. Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel
4. Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
5. Clinical Results for Orameds Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE
6. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
7. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
8. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
9. Oramed Submits New IND Application for Oral Insulin Trial in the US
10. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
11. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , October 24, 2014 ... ) has announced the addition of the  ... 2014"  report to their offering.  ... and Chinese Acne Medication Industry Report 2014 ... the current state of the global acne ...
(Date:10/25/2014)... Oct. 24, 2014  As the building blocks ... company access to diverse skill sets and expertise, ... clock business hours for efficiency. However, effectively managing ... According to recent research, more than ... seeing a project not move forward due to ...
(Date:10/22/2014)... 22, 2014  Rescheduling of hydrocodone combination products ... pain market, according to a new primary market ... providing market research and consultation exclusively in the ... http://photos.prnewswire.com/prnh/20141021/153440 In August, ... combination products from Schedule III to Schedule II ...
Breaking Medicine Technology:Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3
... Ga., June 13, 2011 Friends of Disabled Adults and ... IVC ), providing immediate aid shipments of equipment and supplies ... center of Joplin on May 22, 2011, leaving much of ... was able to send the first supply shipment to Joplin ...
... 2011 Chicago based Share Your Soles marked its twelfth ... celebration for Mona Purdy, Founder of Share Your Soles, but ... to those in need in just over a decade. ... events that provide the necessary support to putting shoes on ...
Cached Medicine Technology:Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3Chicago Based Share Your Soles Expanding to Become Global Shoe Donation Leader 2
(Date:10/25/2014)... WI (PRWEB) October 25, 2014 ... tax-advantaged medical and other benefits account management services, ... to help employers save on taxes, reduce administrative ... Suites provide tax savings and the efficient handling ... pick the Suite that best meets their goals ...
(Date:10/25/2014)... New York (PRWEB) October 25, 2014 ... mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against ... underway in U.S. District Court, Southern District of ... Summary Judgment on Punitive Damages in a group ... In a ruling issued on October 21st, U.S. ...
(Date:10/25/2014)... Oct. 24, 2014 (HealthDay News) -- Not getting the ... ulcerative colitis, a new study suggests. Those who ... eight hours per night may be more prone to ... intestines, researchers report. The study authors concluded that duration ... considered among patients with inflammatory bowel diseases. "Both ...
(Date:10/25/2014)... News) -- October,s shorter, darker days can trigger a ... to an expert. People affected by seasonal ... lack motivation and even have trouble getting out of ... said Dr. Angelos Halaris, a professor in the department ... Stitch School of Medicine. "Seasonal affective disorder should ...
(Date:10/22/2014)... MI (PRWEB) October 22, 2014 ... Schools of Allied Health Professions (ASAHP) Conference on October ... and CEO will participate in a panel discussion on ... Practice. , Isabel Healthcare provides a diagnostic decision support ... improving the diagnosis skills of students and clinical learners. ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2
... manufactured by Merck & Co would result in an increased ... taking the drug. // Statistics show that about 60 patients ... six to 13 days after they first started taking Vioxx. ... Journal. It was contrary to what Merck had previously told ...
... of the Food and Drug Administration has been subjected ... // ,Attorney Barbara Van Gelder has mentioned ... of Lester Crawford. She is believed to have ... Thursday, that she would instruct him to invoke his ...
... and polio immunization campaign commenced with a bit of ... with their children to avail immunization, // and this ... Infact, the stock of vaccines started getting depleted by ... of the vaccination drive. ,Assistant Minister for Medical ...
... hypothermia to help patients with severe heart disease or ... Dalton Dietrich and his colleagues noticed// that the rats ... stroke, but had different responses. ,"We ... temperatures in the rats' brains they found that rates ...
... University Medical School in Melbourne, Australia, it was found ... than a very low-calorie diet.// The surgical procedure consists ... stomach to create a feeling of fullness in patients ... those who have serious medical conditions, such as type ...
... A study conducted by a Brown Medical School professor ... say that postpartum depression is linked to fussy babies.//, ... clinical professor of paediatrics at Brown Medical School and ... Other members include Rhode Island Department of Health's Division ...
Cached Medicine News:
... Used to establish and maintain ... ureteral segment promotes patency and allows ... subsides. Supplied sterile in peel-open packages. ... evaluation is advised; stent must not ...
... drainage following open renal or bladder ... provide enhanced drainage and promote catheter ... for enhanced patient comfort and provides ... Supplied sterile in peel-open packages. Intended ...
... Used for percutaneous ... catheter in the renal ... Supplied sterile in peel-open ... use. CAUTION: Periodic evaluation ...
... contains primers and a FAM-labeled probe targeting the ... Parvo B19 ASR contains primers and a Texas ... ASR requires an instrument that can detect FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
Medicine Products: